Oliceridine

Oliceridine
Clinical data
Pronunciation	OH li SER i deen
Trade names	Olinvyk
Other names	TRV-130, TRV130
AHFS/Drugs.com	Professional Drug Facts
License data	US DailyMed: Oliceridine;
Routes of; administration	Intravenous
ATC code	N02AX07 (WHO) ;
Legal status
Legal status	US: Schedule II;
Identifiers
	IUPAC name N-[(3-Methoxythiophen-2-yl)methyl]-2-[(9R)-9-pyridin-2-yl-6-oxaspiro[4.5]decan-9-yl]ethanamine;
CAS Number	1401028-24-7;
PubChem CID	66553195;
DrugBank	DB14881;
ChemSpider	30841043;
UNII	MCN858TCP0;
KEGG	D11214;
ChEMBL	ChEMBL2443262;
PDB ligand	WH2 (PDBe, RCSB PDB);
CompTox Dashboard (EPA)	DTXSID201031292 ;
Chemical and physical data
Formula	C22H30N2O2S
Molar mass	386.55 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COc1ccsc1CNCC[C@]2(CCOC3(CCCC3)C2)c4ccccn4;
	InChI InChI=1S/C22H30N2O2S/c1-25-18-7-15-27-19(18)16-23-13-10-21(20-6-2-5-12-24-20)11-14-26-22(17-21)8-3-4-9-22/h2,5-7,12,15,23H,3-4,8-11,13-14,16-17H2,1H3/t21-/m1/s1; Key:DMNOVGJWPASQDL-OAQYLSRUSA-N;

Oliceridine, sold under the brand name Olinvyk, is an opioid medication that is used for the treatment of moderate to severe acute pain in adults. It is given by intravenous (IV) injection.

The most common side effects include nausea, vomiting, dizziness, headache, constipation, itchy skin and low oxygen levels in blood.

It was approved for medical use in the United States in August 2020.